Loading clinical trials...
Loading clinical trials...
Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension
Conditions
Interventions
Telmisartan 80mg
Telmisartan 40mg
+1 more
Locations
314
Japan
Boehringer Ingelheim Investigational Site 111
Ageo, Japan
Boehringer Ingelheim Investigational Site 209
Aisho-cho, Japan
Boehringer Ingelheim Investigational Site 22
Aizubange-machi, Japan
Boehringer Ingelheim Investigational Site 234
Akashi, Japan
Boehringer Ingelheim Investigational Site 78
Akiruno, Japan
Boehringer Ingelheim Investigational Site 79
Akishima, Japan
Start Date
January 1, 2010
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
May 1, 2014
NCT02417740
NCT07073820
NCT07480265
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions